Oncolytic virotherapy: Sparking durable anti-tumor immunity through microenvironment modulation. Christoph F Kollmann
Semin Immunol. 2025 Sep 23;80:101994. doi: 10.1016/j.smim.2025.101994. Online ahead of print. ABSTRACT Oncolytic virotherapy (OVT) is a novel approach to cancer treatment that utilizes viruses to infect and destroy tumor cells selectively. Beyond direct oncolysis, OVT significantly reshapes the tumor microenvironment (TME), activating the adaptive immune system to generate robust and durable anti-tumor immunity. This … Read more